iBio Estimates ~500 Million Dose Capacity for COVID-19 Vaccine from its FastPharming Facility™
– Company Expands Involvement in the Manufacturing USA® Network, Joining the National Institute for Innovation in Manufacturing Biopharmaceuticals –NEW YORK […]